Brand Reference: Uroxatral
| Metric | Verified Benchmark | Source |
|---|---|---|
| Alfuzosin Hydrochloride Geomatrix ER RxNorm Concept ID | 17300 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.1950 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $92.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $8.70 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $11.50 / mo | 19 Zero-PHI Verified Patient Logs |
Quinazoline alpha-1 antagonist exhibiting preferential partitioning into prostatic tissue with minimal CNS/vas deferens alpha-1A hyper-blockade—relieving BPH urinary hesitancy with <1.5% retrograde ejaculation incidence compared with tamsulosin or silodosin.
For self-pay patients filling Alfuzosin Hydrochloride Geomatrix ER (NDC 00378-3510-01), direct wholesale and telehealth fulfillment drops monthly spend from $92.00 retail to $8.70 (91% savings against a $0.1950 CMS pharmacy acquisition baseline).
Clinical clearance of Alfuzosin Hydrochloride Geomatrix ER (Ejaculation-Sparing Prostatic Alpha-1 Adrenergic Antagonist) relies on hepatic cyp3a4 oxidation; 70% fecal elimination with a 10 hours half-life; patients absorbing at 49% fed (MUST take immediately after meal; 50% lower if fasting) bioavailability typically observe target onset around 24–72 hours luts stream relief.
FDA clinical labeling for Alfuzosin Hydrochloride Geomatrix ER restricts administration in moderate-to-severe hepatic insufficiency (child-pugh b/c); potent cyp3a4 inhibitors (ritonavir/ketoconazole) across 10 mg ER PO once daily immediately after same meal, with self-reported patient tracking dominated by mild lightheadedness (7% of reports), fatigue (5% of reports), retrograde ejaculation (<1.5%) (1% of reports).
Across 19 verified cash-pay logs, Alfuzosin Hydrochloride Geomatrix ER achieves a 89.50% Worth-It rating with out-of-pocket spend averaging $11.50/mo versus $92.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 10 mg ER PO once daily immediately after same meal for Alfuzosin Hydrochloride Geomatrix ER; monthly out-of-pocket dropped to $7.66 compared with $92.00 retail.
Completed 10 weeks on Alfuzosin Hydrochloride Geomatrix ER (10 mg ER PO once daily immediately after same meal). Zero notable side effects on steady dosing.
Consistent biomarker response on 10 mg ER PO once daily immediately after same meal Alfuzosin Hydrochloride Geomatrix ER sourced via Cost Plus Drugs ($10.09/mo cash pay without insurance prior authorization).